[Toxic shock syndrome. Pathogenesis, diagnosis, therapy].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000992:Antitoxins / Q000627:therapeutic use; D001772:Blood Cell Count; D003102:Colloids / Q000627:therapeutic use; D003221:Confusion / Q000175:diagnosis; D003402:Creatine Kinase / Q000378:metabolism; D004768:Enterotoxins / Q000506:poisoning; D004890:Erythema / Q000175:diagnosis; D005260:Female; D005334:Fever / Q000175:diagnosis; D005440:Fluid Therapy; D006801:Humans; D007527:Isoenzymes / Q000378:metabolism; D007769:Lactams; D008297:Male; D011379:Prognosis; D011817:Rabbits; D012772:Shock, Septic / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D013203:Staphylococcal Infections / Q000150:complications; D013577:Syndrome; D014623:Vaginal Diseases / Q000150:complications; D014883:Water-Electrolyte Imbalance / Q000175:diagnosis
D000900:Anti-Bacterial Agents; D000992:Antitoxins; D003102:Colloids; D004768:Enterotoxins; D007527:Isoenzymes; D007769:Lactams; D003402:Creatine Kinase
Syndrom des toxischen Schocks. Pathogenese, Diagnose, Therapie.